MiniMed Group Inc. Common Stock vs YieldMax NVDA Option Income Strategy ETF — how do they compare? MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B), while YieldMax NVDA Option Income Strategy ETF trades at $12.57 (market cap $1.45B). The key difference: MiniMed Group Inc. Common Stock is far larger — about 3.8× YieldMax NVDA Option Income Strategy ETF's market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| MMED | NVDY | |
|---|---|---|
Market Cap | $5.57B | $1.45B |
Volume | 23,336,073 | 1,943,739 |
Sector | Health | Income / Options Overlay |
52-Week High | $23.84 | $17.21 |
52-Week Low | $10.80 | $11.58 |
Typical Hold Time | 1 Days | 43 Days |
Enterprise Value | $5.37B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY (YieldMax NVDA Option Income Strategy ETF) trades at $12.62, down 3.0% today amid bearish technical signals. The ETF generates income through covered calls on NVIDIA stock but faces structural limitations on upside participation. Recent analyst commentary highlights concerns about NAV erosion despite the attractive 39.7% annualized distribution rate. Technical indicators show bearish momentum with support at $12 and resistance at $13.
The outlook remains cautious as declining NVIDIA volatility reduces option income potential. While weekly distributions provide income, the capped upside and NAV erosion present significant risks for long-term investors. Analyst consensus leans toward Hold ratings, suggesting limited growth prospects despite strong underlying NVIDIA fundamentals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →